Lloyd Old, a researcher and former administrator of two cancer research institutes, passed away this week.
The Scientist
Most Recent
Tagging antibodies with rare earth metals instead of fluorescent molecules turns a veteran technique into a high-throughput powerhouse.
The pharmaceutical darling that has brought billions in revenue to Pfizer over the past 15 years will now share the shelves with its generic competitors.
A special glucose molecule makes tumor cells more vulnerable to a pair of cancer cell-killing drugs.
New congressional proposals would allow drug makers to bypass traditional clinical trial requirements for drugs that address rare diseases.
Are pharmaceuticals in the environment affecting human health?
Researchers scan the molecules in spider venom for anti-cancer effects in tissue culture.
Inadequate poultry immunization programs may cause higher mutations rates in the bird flu virus, rendering the vaccine ineffective and increasing the threat of cross-species transmission.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
